Yutaka Taketani

Yutaka Taketani

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2015 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
YKYuka Kawakami
Yuka Kawakami
HYHisami Yamanaka-Okumura
Hisami Yamanaka-Okumura
YNYuko Naniwa-Kuroki
Yuko Naniwa-Kuroki
MSMasae Sakuma
Masae Sakuma
YTYutaka Taketani
Yutaka Taketani
ETEiji Takeda
Eiji Takeda
The effects of alpha-linolenic acid (ALA) on cardiovascular risk factors considerably vary between published reports. Therefore, we investigated the effects of 12-week supplementation with flaxseed oil (FO), which is a rich source of ALA, on cardiovascular risk factors such as serum small dense low-density lipoprotein (sd-LDL) concentrations. In a randomized, double blind, crossover study, 15 subjects ingested 10 g of FO or corn oil (CO), containing 5.49 g and 0.09 g of ALA, respectively, once daily with dinner. Blood samples were collected at 0, 4 and 12 weeks, and were used for analysis of serum lipid, lipid-related proteins, serum fatty acids and serum sd-LDL cholesterol. Differences during the test period were identified using a repeated-measures analysis of variance (ANOVA) for within-group effects. Group differences were identified using paired t-test at each blood sampling time point. ALA and eicosapentaenoic acid concentrations were significantly higher in the FO period at 4 and 12 weeks than in the CO period. No significant differences in docosahexaenoic acid concentrations were observed between two periods, and cholesteryl ester transfer protein and apolipoprotein B concentrations were significantly lower in the FO period than in the CO period at 12 weeks. FO supplementation was associated with a significant decrease in sd-LDL concentrations at 4 and 12 weeks, and CO supplementation had no effect. Moreover, sd-LDL concentrations were significantly lower in the FO period than in the CO period at 4 weeks. Among subjects with triglyceride (TG) concentrations of >100 mg/dl, FO supplementation markedly reduced sd-LDL concentrations at 4 and 12 weeks compared with baseline. Sd-LDL concentrations significantly differed between the periods at both 4 and 12 weeks. This study indicates that the FO, which is a rich source of ALA, leads to lower sd-LDL cholesterol concentrations.

1 April 2016 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
MAMaerjianghan Abuduli
Maerjianghan Abuduli
HOHirokazu Ohminami
Hirokazu Ohminami
TOTamaki Otani
Tamaki Otani
HKHitoshi Kubo
Hitoshi Kubo
HUHaruka Ueda
Haruka Ueda
YTYutaka Taketani
Yutaka Taketani
Recent epidemiological and animal studies have suggested that excess intake of phosphate (Pi) is a risk factor for the progression of chronic kidney disease and its cardiovascular complications. However, little is known about the impact of dietary high Piintake on the development of metabolic disorders such as obesity and type 2 diabetes. In this study, we investigated the effects of dietary Pion glucose and lipid metabolism in healthy rats. Male 8-wk-old Sprague-Dawley rats were divided into three groups and given experimental diets containing varying amounts of Pi, i.e., 0.2 [low Pi(LP)], 0.6 [control Pi(CP)], and 1.2% [high Pi(HP)]. After 4 wk, the HP group showed lower visceral fat accumulation compared with other groups, accompanied by a low respiratory exchange ratio (V̇co2/V̇o2) without alteration of locomotive activity. The HP group had lower levels of plasma insulin and nonesterified fatty acids. In addition, the HP group also showed suppressed expression of hepatic lipogenic genes, including sterol regulatory element-binding protein-1c, fatty acid synthase, and acetyl-CoA carboxylase, whereas there was no difference in hepatic fat oxidation among the groups. On the other hand, uncoupling protein (UCP) 1 and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) expression were significantly increased in the brown adipose tissue (BAT) of the HP group. Our data demonstrated that a high-Pidiet can negatively regulate lipid synthesis in the liver and increase mRNA expression related to lipid oxidation and UCP1 in BAT, thereby preventing visceral fat accumulation. Thus, dietary Piis a novel metabolic regulator.

1 March 2020 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
Shinta NishiokaShinta Nishioka
Shinta Nishioka
HWHidetaka Wakabayashi
Hidetaka Wakabayashi
KMKeisuke Maeda
Keisuke Maeda
HSHiroshi Shamoto
Hiroshi Shamoto
YTYutaka Taketani
Yutaka Taketani
Ryo MomosakiRyo Momosaki
Ryo Momosaki

10 January 2013 in Endocrinology
Verified
Journal Article
Open access
PDF file
MKMina Kozai
Mina Kozai
HYHironori Yamamoto
Hironori Yamamoto
MIMariko Ishiguro
Mariko Ishiguro
NHNagakatsu Harada
Nagakatsu Harada
MMMasashi Masuda
Masashi Masuda
ETEiji Takeda
Eiji Takeda
The primary determinant of circulating 1α,25-dihydroxyvitamin D (1,25[OH]2D) levels is the activity of 25-hydroxyvitamin D-1α-hydroxylase (cytochrome P450 27B1 [CYP27B1]) in the kidney. Hyperthyroid patients have been reported to have low levels of plasma 1,25(OH)2D. However, the detailed mechanism of thyroid hormone action on vitamin D metabolism is still poorly understood. The present study determined whether renal CYP27B1 gene expression was negatively regulated by thyroid hormones. T3-induced hyperthyroid mice showed marked decreases in plasma 1,25(OH)2D levels and in renal expression of CYP27B1 mRNA but no changes in plasma concentrations of calcium, PTH, or fibroblast growth factor-23. In addition, we observed that T3 administration significantly decreased plasma 1,25(OH)2D and renal CYP27B1 mRNA levels that were increased by low-calcium or low-phosphorus diets and induced hypocalcemia in mice fed a low-calcium diet. Promoter analysis revealed that T3 decreases the basal transcriptional activity of the CYP27B1 gene through thyroid hormone receptors (TRα and TRβ1) and the retinoid X receptor α (RXRα) in renal proximal tubular cells. Interestingly, we identified an everted repeat negative thyroid hormone response element (1α-nTRE) overlapping the sterol regulatory element (1α-SRE) and the TATA-box −50 to −20 base pairs from the human CYP27B1 gene transcription start site. Finally, we established that CYP27B1 gene transcription is positively regulated by SRE-binding proteins and that a T3-bound TRβ1/RXRα heterodimer inhibits SRE-binding protein-1c-induced transcriptional activity through the 1α-nTRE. These results suggest that transcriptional repression of the CYP27B1 gene by T3-bound TRs/RXRα, acting through the 1α-nTRE, results in decreased renal CYP27B1 expression and plasma 1,25(OH)2D levels.

1 January 2017 in Journal of Clinical Biochemistry and Nutrition
Verified
Journal Article
Open access
PDF file
KSKohei Sugihara
Kohei Sugihara
MMMasashi Masuda
Masashi Masuda
MNMari Nakao
Mari Nakao
MAMaerjianghan Abuduli
Maerjianghan Abuduli
YIYukiko Imi
Yukiko Imi
YTYutaka Taketani
Yutaka Taketani
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 January 2018 in Journal of Clinical Biochemistry and Nutrition
Verified
Journal Article
Open access
PDF file
YIYukiko Imi
Yukiko Imi
NYNorie Yabiki
Norie Yabiki
MAMaerjianghan Abuduli
Maerjianghan Abuduli
MMMasashi Masuda
Masashi Masuda
HYHisami Yamanaka-Okumura
Hisami Yamanaka-Okumura
YTYutaka Taketani
Yutaka Taketani
Excessive phosphate intake has been positively associated with renal and vascular dysfunction, conversely negatively associated with body fat accumulation. We investigated the effect of a high-phosphate diet on the expression of lipid metabolic genes in white adipose tissue and liver. Male 8-week-old Sprague–Dawley rats were fed a control diet containing 0.6% phosphate or a high-phosphate diet containing 1.5% phosphate for 4 weeks. In comparison to the control group, the HP group showed a significantly lower body fat mass and fasting plasma insulin level alongside decreased lipogenic and increased lipolytic gene expression in visceral fat. Additionally, the expression of genes involved in hepatic lipogenesis, hepatic glycogenesis, and triglyceride accumulation decreased in the high-phosphate group. Exogenous phosphate, parathyroid hormone, and fibroblast growth factor 23 did not directly affect the expression of lipolytic or lipogenic genes in 3T3-L1 adipocytes and HepG2 hepatocytes. Thus, the high-phosphate diet suppressed the activity of white adipose tissue by increasing lipolytic gene expression and decreasing lipogenic gene expression. These effects could have been caused by the lowered fasting plasma insulin level that occurred in response to the high-phosphate diet, but were not directly caused by the increases in plasma phosphate or phosphaturic hormones.